AGIONasdaq United States
Market cap
$1.927 B
$32.27 +1.00%
Close of 7 Aug 2026
Revenue
$54.0M
#2715 by revenue
Earnings
-$413.0M
Loss-making
Shares outstanding
59,701,882
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Agios Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.